Al final de la Parte III, usted deberá ser capaz de:
1. Describir las siguientes medidas de desigualdad en salud:
- medidas de rango (riesgo relativo, exceso de riesgo);
- medidas basadas en regresión no ponderada;
- medidas basadas en regresión ponderada por población (índice de desigualdad de la pendiente e índice relativo de desigualdad);
- índice de disparidad;
- varianza entre grupos;
- medidas de disproporcionalidad (índice de concentración, Gini, Theil, desviación log media), y
2. Describir las ventajas y desventajas de dichas medidas.
Al final de la Parte IV, usted deberá ser capaz de:
1. describir la secuencia de pasos analíticos para la medición de desigualdades en saludos cuatro posibles escenarios de cambio en las desigualdades en salud y la salud poblacional global a lo largo del tiempo.
2. reconocer los cuatro posibles escenarios de cambio en las desigualdades en salud y la salud poblacional global a lo largo del tiempo.
- Know basic concepts regarding pneumococcal epidemiology, transmission, and distribution;
- Identify those groups most susceptible to pneumococcal disease;
- Recognize the importance of pneumococcal disease as a public health problem;
- Understand pneumococcal disease burden and how it varies between developing and developed countries;
- Distinguish characteristics of specific pneumococcal disease syndromes.
- Describe practical methods for collecting surveillance data;
- Understand how surveillance data guide decisions related to pneumococcal vaccine introduction;
- Learn how to use surveillance data to estimate disease burden.
- Recognize the main types of pneumococcal vaccines;
- Understand the ways in which the PCV-7 vaccine prevents pneumococcal infections;
- Estimate the potential impact of pneumococcal vaccine introduction in your country.
- Evaluate data to choose the most appropriate vaccine;
- Determine financing options;
- Assess the capacity needs of the health system;
- Recognize procurement and regulatory needs;
- Support advocacy and communication activities.
- Understand the different methods for evaluating the economics of health interventions, such as introducing a new vaccine;
- Understand how to use a cost-effectiveness analysis (CEA) to measure the costs and benefits of introducing a rotavirus vaccine;
- Identify the main drivers of CEA for a rotavirus vaccine;
- Conduct a cost analysis for introducing a rotavirus vaccine.
- Define the rationale for advocacy on rotavirus vaccines;
- Prepare tools for spreading advocacy messages;
- Identify different audiences for outreach;
- Plan for crisis communications.
- Monitor the reach of the rotavirus immunization program through recording immunization coverage;
- Evaluate the impact of the rotavirus immunization program through monitoring disease incidence.
